Header Logo

Eliza Chakravarty

Concepts (397)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pregnancy Complications
21
2021
108
5.400
Why?
Lupus Erythematosus, Systemic
30
2021
988
4.040
Why?
Antirheumatic Agents
17
2018
56
3.700
Why?
Rheumatic Diseases
10
2018
33
3.490
Why?
Arthritis, Rheumatoid
16
2018
133
3.320
Why?
Immunosuppressive Agents
11
2020
142
2.910
Why?
Herpes Zoster
8
2017
20
2.810
Why?
Pregnancy Outcome
15
2021
130
2.120
Why?
Herpes Zoster Vaccine
5
2017
10
2.060
Why?
Autoimmune Diseases
7
2017
162
1.630
Why?
Pregnancy
27
2021
1154
1.530
Why?
Scleroderma, Systemic
5
2012
29
1.270
Why?
Female
62
2021
14662
1.240
Why?
Humans
78
2021
27168
1.190
Why?
Hospitalization
6
2017
187
1.110
Why?
Maternal Exposure
3
2018
17
1.100
Why?
Lupus Nephritis
3
2019
99
1.010
Why?
Primary Ovarian Insufficiency
2
2021
6
0.900
Why?
Adult
36
2020
7506
0.830
Why?
Autoantibodies
4
2020
472
0.790
Why?
Menopause, Premature
1
2020
3
0.720
Why?
Cyclophosphamide
1
2020
39
0.710
Why?
Reproductive Health
2
2018
5
0.700
Why?
Ovary
1
2020
69
0.700
Why?
Lactation
3
2021
56
0.630
Why?
Middle Aged
27
2020
6913
0.620
Why?
Drug Labeling
1
2018
4
0.610
Why?
United States Food and Drug Administration
1
2018
43
0.590
Why?
Running
2
2008
39
0.590
Why?
Abatacept
2
2015
5
0.590
Why?
Risk Factors
14
2021
2038
0.580
Why?
Certolizumab Pegol
1
2017
2
0.580
Why?
Gene Expression
2
2020
408
0.580
Why?
Herpesvirus 3, Human
2
2017
12
0.580
Why?
United States
12
2018
2068
0.570
Why?
Fetal Blood
1
2017
38
0.570
Why?
Abnormalities, Drug-Induced
3
2014
10
0.560
Why?
Vaccination
2
2021
177
0.540
Why?
Uterine Cervical Dysplasia
1
2017
35
0.540
Why?
Patient Participation
3
2020
53
0.520
Why?
Severity of Illness Index
9
2018
446
0.510
Why?
Tumor Necrosis Factor-alpha
4
2015
243
0.500
Why?
Skin Neoplasms
2
2008
119
0.500
Why?
Scleroderma, Diffuse
1
2015
2
0.490
Why?
CD28 Antigens
1
2015
11
0.490
Why?
Antibodies, Monoclonal
4
2011
318
0.490
Why?
Papillomavirus Infections
1
2017
137
0.490
Why?
Male
28
2020
13041
0.470
Why?
Antibodies, Monoclonal, Murine-Derived
3
2011
41
0.460
Why?
Premature Birth
2
2013
49
0.460
Why?
Preconception Care
2
2014
17
0.450
Why?
Family Planning Services
1
2014
6
0.450
Why?
Uterine Cervical Neoplasms
1
2017
285
0.450
Why?
Fetal Growth Retardation
2
2012
30
0.450
Why?
Delivery, Obstetric
3
2017
38
0.440
Why?
Aged
18
2020
5234
0.440
Why?
Gastrointestinal Diseases
1
2014
54
0.430
Why?
Biological Products
1
2014
60
0.420
Why?
Physician-Patient Relations
1
2014
112
0.410
Why?
Incidence
5
2016
553
0.390
Why?
Disabled Persons
1
2012
18
0.390
Why?
Disability Evaluation
3
2008
53
0.390
Why?
Mixed Connective Tissue Disease
2
2015
3
0.380
Why?
Breast Neoplasms
1
2017
448
0.380
Why?
Infant, Low Birth Weight
1
2011
23
0.370
Why?
Hypertension
2
2012
304
0.370
Why?
Remission, Spontaneous
1
2010
8
0.360
Why?
Longevity
1
2012
129
0.350
Why?
Health Behavior
1
2012
154
0.350
Why?
Antiphospholipid Syndrome
2
2007
30
0.340
Why?
Antibodies, Antinuclear
4
2020
181
0.340
Why?
Clinical Trials as Topic
3
2020
206
0.340
Why?
Exercise
2
2012
469
0.340
Why?
Lymphocyte Activation
4
2020
207
0.340
Why?
Self Disclosure
1
2009
5
0.330
Why?
Databases as Topic
1
2009
21
0.330
Why?
Epilepsy
1
2009
34
0.330
Why?
Arthritis
1
2009
29
0.320
Why?
Practice Patterns, Physicians'
2
2018
160
0.320
Why?
Rheumatology
2
2021
17
0.320
Why?
Immunologic Factors
4
2015
48
0.310
Why?
Virus Latency
1
2008
9
0.310
Why?
Immunoglobulin G
4
2014
267
0.310
Why?
Multiple Sclerosis
1
2009
81
0.310
Why?
Virus Diseases
1
2008
38
0.300
Why?
Mortality
1
2008
43
0.300
Why?
Osteoarthritis, Knee
1
2008
24
0.290
Why?
Hypertension, Pulmonary
1
2008
30
0.290
Why?
Infant, Newborn
4
2018
846
0.290
Why?
Databases, Factual
5
2018
251
0.290
Why?
Anemia, Sickle Cell
1
2008
38
0.290
Why?
Hypertension, Malignant
1
2007
3
0.280
Why?
Cross-Sectional Studies
4
2020
931
0.280
Why?
Hospital Mortality
1
2007
145
0.270
Why?
Melanoma
1
2008
128
0.270
Why?
Methotrexate
2
2005
32
0.270
Why?
Interferon-alpha
3
2018
50
0.270
Why?
Surveys and Questionnaires
6
2018
934
0.270
Why?
Dendritic Cells
2
2018
142
0.260
Why?
Research Design
1
2007
175
0.250
Why?
Prospective Studies
3
2017
1221
0.250
Why?
Opportunistic Infections
2
2021
15
0.250
Why?
Treatment Outcome
5
2020
2286
0.250
Why?
Multivariate Analysis
4
2014
300
0.250
Why?
Prenatal Exposure Delayed Effects
2
2018
100
0.240
Why?
Giant Cells
1
2005
1
0.240
Why?
Coronary Disease
1
2005
118
0.240
Why?
Antineoplastic Agents
1
2010
660
0.240
Why?
Registries
3
2020
382
0.240
Why?
Myocarditis
1
2005
21
0.230
Why?
Neoplasms
2
2004
768
0.230
Why?
Natural Killer T-Cells
2
2016
54
0.230
Why?
Aging
1
2012
952
0.230
Why?
Paraneoplastic Syndromes
1
2004
8
0.230
Why?
Purpura, Thrombotic Thrombocytopenic
1
2007
216
0.230
Why?
Anti-Inflammatory Agents
3
2018
111
0.220
Why?
Carcinoma, Squamous Cell
1
2005
155
0.220
Why?
Practice Guidelines as Topic
2
2017
235
0.220
Why?
Time Factors
3
2020
1571
0.220
Why?
Risk Assessment
4
2021
598
0.210
Why?
Echocardiography
2
2018
108
0.210
Why?
Adolescent
5
2017
2993
0.210
Why?
Aged, 80 and over
5
2014
1944
0.210
Why?
Longitudinal Studies
4
2014
405
0.200
Why?
Biomarkers
4
2020
738
0.200
Why?
Young Adult
6
2017
2633
0.200
Why?
Rituximab
3
2011
60
0.200
Why?
Length of Stay
3
2008
216
0.190
Why?
B-Lymphocytes
2
2018
278
0.190
Why?
California
3
2007
66
0.190
Why?
Diagnosis, Differential
4
2007
367
0.190
Why?
Pre-Eclampsia
3
2006
48
0.180
Why?
Infant
2
2017
965
0.180
Why?
Retrospective Studies
6
2018
2453
0.180
Why?
Ambulatory Care
1
2021
58
0.180
Why?
Body Mass Index
3
2014
387
0.180
Why?
Gestational Age
3
2013
141
0.170
Why?
Infertility
1
2021
35
0.170
Why?
African Americans
2
2020
350
0.170
Why?
Cohort Studies
5
2015
862
0.170
Why?
Fetal Death
2
2013
21
0.170
Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
66
0.170
Why?
Biomedical Research
2
2018
93
0.170
Why?
Patient Care Management
1
2019
10
0.160
Why?
Withholding Treatment
1
2019
20
0.160
Why?
Survival Analysis
2
2012
278
0.160
Why?
Autoimmunity
1
2020
154
0.160
Why?
Breast Feeding
2
2010
87
0.160
Why?
Follow-Up Studies
4
2018
989
0.160
Why?
T-Lymphocytes
1
2020
279
0.150
Why?
Prenatal Diagnosis
1
2018
17
0.150
Why?
Heart Block
1
2018
43
0.150
Why?
B-Cell Activating Factor
2
2020
31
0.150
Why?
Decision Making
1
2020
172
0.150
Why?
Herpesvirus 4, Human
1
2018
41
0.150
Why?
Viral Proteins
1
2018
62
0.150
Why?
Health Surveys
2
2009
78
0.150
Why?
Interleukin-10
1
2018
68
0.150
Why?
Menopause
1
2018
28
0.150
Why?
Receptors, Antigen, T-Cell
2
2016
76
0.150
Why?
Hypertension, Pregnancy-Induced
1
2017
8
0.150
Why?
Luminescent Measurements
1
2017
30
0.140
Why?
Product Surveillance, Postmarketing
1
2017
12
0.140
Why?
Double-Blind Method
3
2015
405
0.140
Why?
Dermatomyositis
1
2017
60
0.140
Why?
Linear Models
2
2008
201
0.140
Why?
Activities of Daily Living
1
2018
101
0.140
Why?
Monocytes
1
2018
133
0.140
Why?
Neutrophils
1
2018
179
0.140
Why?
Inflammation
3
2020
608
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2020
284
0.140
Why?
Prednisone
4
2014
51
0.140
Why?
Placenta
1
2017
74
0.140
Why?
Sjogren's Syndrome
1
2020
261
0.130
Why?
Patient Compliance
1
2017
75
0.130
Why?
Proportional Hazards Models
2
2008
217
0.130
Why?
West Nile virus
1
2016
20
0.130
Why?
Papillomavirus Vaccines
1
2017
53
0.130
Why?
Guideline Adherence
1
2017
91
0.130
Why?
Osteoarthritis
2
2007
35
0.130
Why?
T-Lymphocyte Subsets
1
2016
57
0.130
Why?
Quality of Life
2
2018
468
0.130
Why?
Kidney Failure, Chronic
1
2016
68
0.130
Why?
Smoking
2
2012
466
0.130
Why?
Early Detection of Cancer
1
2017
122
0.130
Why?
Pilot Projects
3
2013
397
0.130
Why?
Obstetric Labor, Premature
2
2006
15
0.120
Why?
Cesarean Section
2
2006
55
0.120
Why?
Hydroxychloroquine
2
2013
19
0.120
Why?
Kidney
1
2016
276
0.120
Why?
DNA-Binding Proteins
1
2018
481
0.120
Why?
Interleukin-17
1
2015
51
0.120
Why?
Transcription Factors
1
2018
512
0.120
Why?
Oligonucleotide Array Sequence Analysis
1
2015
190
0.120
Why?
Fertility
1
2015
58
0.120
Why?
Antigens, CD1d
1
2014
45
0.120
Why?
Maternal-Fetal Exchange
1
2014
10
0.110
Why?
Oligopeptides
1
2015
95
0.110
Why?
CD4-Positive T-Lymphocytes
1
2015
103
0.110
Why?
Immunity
1
2014
26
0.110
Why?
Protein Array Analysis
1
2013
18
0.110
Why?
Signal Transduction
1
2020
1379
0.110
Why?
Vitamin D Deficiency
1
2014
31
0.110
Why?
Immunocompromised Host
1
2013
27
0.110
Why?
Contraindications
1
2013
13
0.110
Why?
Antibodies, Monoclonal, Humanized
2
2011
133
0.100
Why?
Chronic Disease
1
2014
264
0.100
Why?
Abortion, Spontaneous
1
2012
16
0.100
Why?
Autoantigens
1
2013
212
0.100
Why?
Family Characteristics
1
2012
46
0.100
Why?
Infertility, Female
1
2012
43
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
19
0.090
Why?
Mycophenolic Acid
1
2011
16
0.090
Why?
Chi-Square Distribution
2
2010
144
0.090
Why?
Odds Ratio
2
2010
230
0.090
Why?
Immunoconjugates
1
2011
17
0.090
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2014
73
0.090
Why?
Managed Care Programs
1
2011
16
0.090
Why?
Comorbidity
1
2012
250
0.090
Why?
Pregnancy, Unplanned
1
2010
5
0.090
Why?
Sex Factors
2
2013
452
0.090
Why?
Case-Control Studies
2
2014
707
0.090
Why?
Contraception
1
2010
21
0.090
Why?
Lymphoma
1
2010
22
0.090
Why?
Counseling
1
2010
54
0.090
Why?
Cytokines
3
2020
441
0.090
Why?
Medicare
1
2011
122
0.090
Why?
Quality Assurance, Health Care
1
2010
62
0.080
Why?
Osteoporosis
1
2010
63
0.080
Why?
Confidence Intervals
1
2009
66
0.080
Why?
Survival Rate
1
2010
411
0.080
Why?
Disease Progression
3
2018
458
0.080
Why?
United States Department of Veterans Affairs
1
2009
26
0.080
Why?
Diagnostic Errors
1
2009
32
0.080
Why?
Prevalence
2
2009
478
0.080
Why?
Fibromyalgia
1
2009
12
0.080
Why?
DNA Viruses
1
2008
3
0.080
Why?
Hepatitis B, Chronic
1
2008
6
0.080
Why?
Polyomavirus Infections
1
2008
7
0.080
Why?
Hepacivirus
1
2008
47
0.080
Why?
Hepatitis C
1
2008
40
0.070
Why?
Immunoglobulin M
1
2007
28
0.070
Why?
Pregnancy Complications, Hematologic
1
2008
38
0.070
Why?
Age Distribution
1
2007
70
0.070
Why?
Radiography
1
2008
201
0.070
Why?
Sex Distribution
1
2007
76
0.070
Why?
Probability
1
2007
75
0.070
Why?
Dose-Response Relationship, Drug
4
2014
589
0.070
Why?
Erythrocytes, Abnormal
1
2007
13
0.070
Why?
Pennsylvania
1
2007
10
0.070
Why?
International Cooperation
1
2007
18
0.070
Why?
Inpatients
1
2007
56
0.070
Why?
Anemia, Hemolytic
1
2007
22
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2020
253
0.070
Why?
Seizures
1
2007
46
0.070
Why?
Data Interpretation, Statistical
1
2007
56
0.070
Why?
Skin Diseases, Vascular
1
2006
3
0.070
Why?
Erythrocytes
1
2007
83
0.070
Why?
Musculoskeletal Diseases
1
2006
5
0.070
Why?
Epidemiologic Methods
1
2006
21
0.070
Why?
Plasma Exchange
1
2007
103
0.070
Why?
Recombinant Fusion Proteins
1
2007
229
0.070
Why?
Vascular Diseases
1
2007
67
0.070
Why?
Fetal Membranes, Premature Rupture
1
2006
5
0.060
Why?
Age Factors
1
2008
725
0.060
Why?
Phenotype
2
2020
668
0.060
Why?
Software
1
2007
121
0.060
Why?
Vaccines, Inactivated
1
2005
4
0.060
Why?
Mycobacterium
1
2005
3
0.060
Why?
Immunotherapy, Active
1
2005
6
0.060
Why?
Thrombocytopenia
1
2007
112
0.060
Why?
Carcinoma, Basal Cell
1
2005
12
0.060
Why?
Cyclooxygenase 2 Inhibitors
1
2005
18
0.060
Why?
Bacterial Vaccines
1
2005
28
0.060
Why?
Medical Records
1
2005
49
0.060
Why?
Coronary Artery Bypass
1
2005
68
0.060
Why?
Pyrazoles
1
2005
62
0.060
Why?
Coronary Angiography
1
2005
150
0.060
Why?
Prognosis
2
2018
763
0.060
Why?
Sulfonamides
1
2005
70
0.060
Why?
Warfarin
1
2005
94
0.060
Why?
Diabetes, Gestational
1
2006
67
0.060
Why?
Fatal Outcome
1
2005
67
0.060
Why?
Risk
1
2004
133
0.060
Why?
Oklahoma
2
2020
979
0.060
Why?
Hemorrhage
1
2005
260
0.050
Why?
Anticoagulants
1
2005
293
0.050
Why?
Etanercept
1
2003
6
0.050
Why?
Infliximab
1
2003
6
0.050
Why?
Isoxazoles
1
2003
7
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2003
18
0.050
Why?
Syndrome
1
2003
78
0.050
Why?
Data Collection
1
2003
102
0.050
Why?
Vitamin D
2
2014
48
0.050
Why?
Attitude of Health Personnel
1
2003
139
0.050
Why?
Logistic Models
2
2014
398
0.050
Why?
Protective Factors
1
2021
16
0.050
Why?
Delphi Technique
1
2021
17
0.050
Why?
Consensus
1
2021
69
0.040
Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2020
3
0.040
Why?
Chemokine CXCL9
1
2020
3
0.040
Why?
Chemokine CXCL13
1
2020
7
0.040
Why?
Interleukin-1alpha
1
2020
7
0.040
Why?
Altruism
1
2020
8
0.040
Why?
Chemokine CXCL10
1
2020
22
0.040
Why?
Culture
1
2020
26
0.040
Why?
Interferons
1
2020
68
0.040
Why?
Gene Regulatory Networks
1
2020
76
0.040
Why?
Focus Groups
1
2020
90
0.040
Why?
Minority Groups
1
2020
64
0.040
Why?
Perception
1
2020
84
0.040
Why?
Models, Statistical
1
2020
122
0.040
Why?
Interleukins
1
2020
111
0.040
Why?
Antigens, Differentiation, Myelomonocytic
1
2018
14
0.040
Why?
Qualitative Research
1
2020
176
0.040
Why?
Pregnancy Trimesters
1
2018
5
0.040
Why?
Genetic Association Studies
1
2018
110
0.040
Why?
Reproductive History
1
2018
8
0.040
Why?
STAT3 Transcription Factor
1
2018
92
0.040
Why?
Receptors, Cell Surface
1
2018
111
0.040
Why?
Antigens, CD
1
2018
134
0.040
Why?
Maternal Age
1
2017
25
0.040
Why?
Transcriptome
1
2018
205
0.030
Why?
Cytopathogenic Effect, Viral
1
2016
3
0.030
Why?
Gene Expression Regulation, Viral
1
2016
12
0.030
Why?
West Nile Fever
1
2016
15
0.030
Why?
Genome, Viral
1
2016
28
0.030
Why?
Animals
3
2015
10093
0.030
Why?
Coculture Techniques
1
2016
54
0.030
Why?
Immunophenotyping
1
2016
59
0.030
Why?
Immunity, Innate
1
2018
214
0.030
Why?
Virus Replication
1
2016
63
0.030
Why?
Kaplan-Meier Estimate
1
2016
189
0.030
Why?
RNA, Viral
1
2016
68
0.030
Why?
Biopsy
1
2016
202
0.030
Why?
Inflammation Mediators
1
2016
154
0.030
Why?
Perinatal Care
1
2015
4
0.030
Why?
Gene Expression Regulation
1
2018
626
0.030
Why?
Lymphocyte Depletion
1
2014
8
0.030
Why?
CD40 Ligand
1
2014
13
0.030
Why?
Patient Safety
1
2015
36
0.030
Why?
Primary Cell Culture
1
2014
27
0.030
Why?
Mice
2
2015
4478
0.030
Why?
Plasma Cells
1
2014
21
0.030
Why?
Cell Separation
1
2014
55
0.030
Why?
Protein Binding
1
2016
637
0.030
Why?
Antibodies, Neutralizing
1
2014
69
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2014
19
0.030
Why?
STAT1 Transcription Factor
1
2014
37
0.030
Why?
Mycobacterium Infections
1
2013
1
0.030
Why?
Polyendocrinopathies, Autoimmune
1
2013
1
0.030
Why?
Ultraviolet Rays
1
2014
40
0.030
Why?
Estrogens
1
2014
56
0.030
Why?
Cells, Cultured
1
2016
978
0.030
Why?
Phosphorylation
1
2015
568
0.030
Why?
Glucocorticoids
1
2014
114
0.030
Why?
Antibody Specificity
1
2013
114
0.030
Why?
Fetal Distress
1
2013
1
0.030
Why?
Recurrence
1
2014
317
0.030
Why?
Siblings
1
2013
23
0.030
Why?
Congenital Abnormalities
1
2013
16
0.030
Why?
Recombinant Proteins
1
2013
408
0.020
Why?
Cell Differentiation
1
2014
398
0.020
Why?
Reproducibility of Results
1
2014
751
0.020
Why?
Diagnosis-Related Groups
1
2011
10
0.020
Why?
San Francisco
1
2010
8
0.020
Why?
Insurance, Health
1
2011
51
0.020
Why?
Bone Density Conservation Agents
1
2010
18
0.020
Why?
Residence Characteristics
1
2011
101
0.020
Why?
Socioeconomic Factors
1
2011
242
0.020
Why?
Indians, North American
1
2014
518
0.020
Why?
Bone Density
1
2010
99
0.020
Why?
Calcium
1
2010
232
0.020
Why?
Sensitivity and Specificity
1
2010
510
0.020
Why?
Fatigue
1
2009
63
0.020
Why?
Dietary Supplements
1
2010
221
0.020
Why?
Antibodies, Anti-Idiotypic
1
2007
16
0.020
Why?
RNA, Double-Stranded
1
2007
15
0.020
Why?
Complement C3
1
2007
21
0.020
Why?
Adalimumab
1
2007
3
0.020
Why?
Hand
1
2007
25
0.020
Why?
Cartilage, Articular
1
2007
43
0.020
Why?
Abdomen
1
2006
41
0.020
Why?
Forearm
1
2006
39
0.020
Why?
Infusions, Intravenous
1
2006
99
0.020
Why?
Lymphoma, Non-Hodgkin
1
2006
22
0.020
Why?
Pain
1
2009
254
0.020
Why?
Kidney Transplantation
1
2006
44
0.020
Why?
Injections, Intradermal
1
2005
2
0.020
Why?
Thrombomodulin
1
2005
10
0.020
Why?
Celecoxib
1
2005
9
0.020
Why?
Leg
1
2006
131
0.020
Why?
E-Selectin
1
2005
27
0.020
Why?
Hospitals, Teaching
1
2005
25
0.020
Why?
Drug Interactions
1
2005
78
0.020
Why?
Drug Therapy, Combination
1
2005
205
0.010
Why?
Cell Proliferation
1
2007
775
0.010
Why?
Chakravarty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (397)
Explore
_
Co-Authors (21)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_